Realbotix Sells Subsidiary Onconetix in All-Stock Transaction

jueves, 12 de febrero de 2026, 8:47 am ET1 min de lectura
ONCO--

Realbotix has announced the sale of its wholly owned subsidiary, RealLLC, to Onconetix in an all-stock transaction. RealLLC focuses on the research and development of AI-powered humanoid robots. The acquisition is expected to strengthen Onconetix's capabilities in the field of robotics and artificial intelligence.

Realbotix Sells Subsidiary Onconetix in All-Stock Transaction

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios